Engineering living therapeutics with synthetic biology

Andrés Cubillos-Ruiz(Massachusetts Institute of Technology), Tingxi Guo(Massachusetts Institute of Technology), Anna Sokolovska(Synlogic (United States)), Paul Miller, James J. Collins(Massachusetts Institute of Technology), Timothy K. Lu(Massachusetts Institute of Technology), José M. Lora(InterScience (United States))

Nature Reviews Drug Discovery

October 6, 2021

10.1038/s41573-021-00285-3

Cited by 317

Abstract

Related Papers

A synthetic oscillatory network of transcriptional regulators

Michael B. Elowitz, Stanislas Leibler|Nature|2000|4.8k

T Cells Targeting Carcinoembryonic Antigen Can Mediate Regression of Metastatic Colorectal Cancer but Induce Severe Transient Colitis

Maria R. Parkhurst, James C. Yang, Russell C. Langan et al.|Molecular Therapy|2010|1k

The treatment of malignant tumors by repeated inoculations of erysipelas. With a report of ten original cases. 1893.

WILLIAM B. COLEY|PubMed|1991|975

A brief history of synthetic biology

D. Ewen Cameron, Caleb J. Bashor, James J. Collins|Nature Reviews Microbiology|2014|931

Engineering the perfect (bacterial) cancer therapy

Neil S. Forbes|Nature reviews. Cancer|2010|892